Analysis of the fibroblastic growth factor receptor-RAS/RAF/MEK/ERK-ETS2/brachyury signalling pathway in chordomas
Asem Shalaby(CRUK Lung Cancer Centre of Excellence), Adrienne M. Flanagan(Institute of Structural and Molecular Biology)
Cited by 38
Related Papers
Potential therapeutic targets for chordoma: PI3K/AKT/TSC1/TSC2/mTOR pathway
|British Journal of Cancer|2009|118
Analysis of Immunohistochemical Expression of BRAF (V600E) Mutation in Serrated Colorectal Polyps: A Study from Tertiary Hospital in Oman
|Asian Pacific Journal of Cancer Prevention|2024|1